Sangamo Therapeutics Company
Sangamo Therapeutics is a genomic medicine company conducting research & development across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation.
Technology:
Others
Funding Status:
IPO
Total Funding:
$74 M
Industry:
Genomic and Epigenominc Instabillity
Estimated Revenue:
$10M to $50M
Founded Date:
01.01.1995
Headquarters:
United States
Employee Number:
251-500